Milan 2012 Programme Registration Exhibition Hotels Exhibitor Listing Satellite Meetings Visa Information
Search Abstracts by author or title
(results will display both Free Papers & Poster)

Combined femtoLASIK and corneal inlay to treat hyperopic presbyopia: six-month results

Poster Details

First Author: M.Fantozzi ITALY

Co Author(s):    A. Malandrini   L. Menaboni   A. Catanese   C. Lenzetti   I. Lenzetti  

Abstract Details


To evaluate a combined refractive treatment to improve near vision in presbyopic patient with hyperopia.


Ophthalmology Unit, " Misericordia e Dolce" Hospital, Prato, Italy


A prospective, nonrandomized, clinical study of 26 eyes of 13 hyperopic patients (mean age was 52.87±3.64 years) who had undergone bilateral laser in situ keratomileusis (LASIK) to correct their hyperopia using 150 kHz AMO Intralase femtosecond laser and, three months later, who had undergone implant of corneal inlay (Flexivue Microlens, Presbia) in their non dominant eye to correct presbyopia. Mean preoperative refractive error was +1.89 ± 0.75 diopters (D) sphere with 0.54 ± 0.36 D cylinder: all patients received full distance refractive correction. All patients were required to attend follow up at 1 week and 1,3 and 6 months: visual outcomes, contrast sensivity, topography and confocal microscopy were evaluated


Six months after combined surgery, uncorrected distance visual acuity was 20/40 or better in 81% of operated eyes and 20/25 or better in all patients binocularly, whereas monocular mean uncorrected near visual acuity was 20/25–20/16 in 81% and 20/40-20/30 in 19% of operated eyes. Contrast sensivity reduction was clinically insignificant and no tissue alterations were found using corneal confocal microscopy.


Combined surgery with hyperopic LASIK and corneal inlay was effective and stable over 6 months, yielding improvement in distance and near visual acuity: Flexivue microlens caused minimal impact on UDVA or mesopic contrast sensitivity in the implanted eye. This treatment significantly reduced spectacle dependence. FINANCIAL DISCLOSURE?: No

Back to previous

loading Please wait while information is loading.